Product Code: ETC12837566 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Inflammatory Bowel Therapeutics Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Inflammatory Bowel Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Inflammatory Bowel Therapeutics Market - Industry Life Cycle |
3.4 Australia Inflammatory Bowel Therapeutics Market - Porter's Five Forces |
3.5 Australia Inflammatory Bowel Therapeutics Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Australia Inflammatory Bowel Therapeutics Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.7 Australia Inflammatory Bowel Therapeutics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Australia Inflammatory Bowel Therapeutics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Inflammatory Bowel Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of inflammatory bowel diseases in Australia |
4.2.2 Growing awareness and diagnosis rates of inflammatory bowel diseases |
4.2.3 Advancements in therapeutic options for inflammatory bowel diseases |
4.3 Market Restraints |
4.3.1 High cost of treatment for inflammatory bowel diseases |
4.3.2 Stringent regulatory requirements for drug approval in Australia |
4.3.3 Limited access to specialized healthcare facilities in certain regions |
5 Australia Inflammatory Bowel Therapeutics Market Trends |
6 Australia Inflammatory Bowel Therapeutics Market, By Types |
6.1 Australia Inflammatory Bowel Therapeutics Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Inflammatory Bowel Therapeutics Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Australia Inflammatory Bowel Therapeutics Market Revenues & Volume, By Biologics (TNF inhibitors, Integrin inhibitors, IL inhibitors), 2021 - 2031F |
6.1.4 Australia Inflammatory Bowel Therapeutics Market Revenues & Volume, By Small Molecule Drugs (Aminosalicylates, Corticosteroids, Immunomodulators, JAK inhibitors), 2021 - 2031F |
6.2 Australia Inflammatory Bowel Therapeutics Market, By Disease Type |
6.2.1 Overview and Analysis |
6.2.2 Australia Inflammatory Bowel Therapeutics Market Revenues & Volume, By Crohns Disease, 2021 - 2031F |
6.2.3 Australia Inflammatory Bowel Therapeutics Market Revenues & Volume, By Ulcerative Colitis, 2021 - 2031F |
6.3 Australia Inflammatory Bowel Therapeutics Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Australia Inflammatory Bowel Therapeutics Market Revenues & Volume, By Oral, 2021 - 2031F |
6.3.3 Australia Inflammatory Bowel Therapeutics Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.4 Australia Inflammatory Bowel Therapeutics Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Australia Inflammatory Bowel Therapeutics Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.3 Australia Inflammatory Bowel Therapeutics Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.4.4 Australia Inflammatory Bowel Therapeutics Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
7 Australia Inflammatory Bowel Therapeutics Market Import-Export Trade Statistics |
7.1 Australia Inflammatory Bowel Therapeutics Market Export to Major Countries |
7.2 Australia Inflammatory Bowel Therapeutics Market Imports from Major Countries |
8 Australia Inflammatory Bowel Therapeutics Market Key Performance Indicators |
8.1 Patient adherence rates to prescribed inflammatory bowel therapeutics |
8.2 Number of clinical trials and research studies conducted on new treatment options |
8.3 Rate of adoption of advanced technologies in the management of inflammatory bowel diseases |
9 Australia Inflammatory Bowel Therapeutics Market - Opportunity Assessment |
9.1 Australia Inflammatory Bowel Therapeutics Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Australia Inflammatory Bowel Therapeutics Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.3 Australia Inflammatory Bowel Therapeutics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Australia Inflammatory Bowel Therapeutics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Inflammatory Bowel Therapeutics Market - Competitive Landscape |
10.1 Australia Inflammatory Bowel Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Australia Inflammatory Bowel Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |